Aqueduct Critical Care

Bothell, United States Founded: 2013 • Age: 13 yrs
Novel products to manage Cerebral Spinal Fluid (CSF) pressure
Request Access

About Aqueduct Critical Care

Aqueduct Critical Care is a company based in Bothell (United States) founded in 2013.. Aqueduct Critical Care has raised $10.25 million across 4 funding rounds. The company has 13 employees as of December 31, 2022. Aqueduct Critical Care operates in a competitive market with competitors including CereVasc, IRRAS, Longeviti, Tissuemed and Aqueduct Neurosciences, among others.

  • Headquarter Bothell, United States
  • Employees 13 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Aqueduct Critical Care, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.25 M (USD)

    in 4 rounds

  • Latest Funding Round
    $821.62 K (USD), Series A

    Jun 13, 2018

  • Investors
  • Employee Count
    13

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Aqueduct Critical Care

Aqueduct Critical Care has successfully raised a total of $10.25M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $821.62 thousand completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $821,617
  • First Round

    (10 May 2016)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2018 Amount Series A - Aqueduct Critical Care Valuation

investors

Sep, 2017 Amount Series A - Aqueduct Critical Care Valuation

investors

Jan, 2017 Amount Series A - Aqueduct Critical Care Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Aqueduct Critical Care

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aqueduct Critical Care

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aqueduct Critical Care Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aqueduct Critical Care

Aqueduct Critical Care operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CereVasc, IRRAS, Longeviti, Tissuemed and Aqueduct Neurosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
eShunt device is developed for communicating hydrocephalus treatment.
domain founded_year HQ Location
Provider of devices for fluid control and management after surgery
domain founded_year HQ Location
Implantable neurosurgical devices are developed for cranial defect correction.
domain founded_year HQ Location
Bioadhesive films are developed to seal leaks in surgical procedures.
domain founded_year HQ Location
Develops implantable shunts to treat hydrocephalus.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aqueduct Critical Care

Frequently Asked Questions about Aqueduct Critical Care

When was Aqueduct Critical Care founded?

Aqueduct Critical Care was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Where is Aqueduct Critical Care located?

Aqueduct Critical Care is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.

Is Aqueduct Critical Care a funded company?

Aqueduct Critical Care is a funded company, having raised a total of $10.25M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.01M, raised on May 10, 2016.

How many employees does Aqueduct Critical Care have?

As of Dec 31, 2022, the latest employee count at Aqueduct Critical Care is 13.

What does Aqueduct Critical Care do?

Aqueduct Critical Care was founded in 2013 and is based in Bothell, United States. Products are developed by the company within the medical device sector to control cerebral spinal fluid (CSF) pressure and flow for patients in critical care after brain surgery. Inter-cranial pressure challenges are addressed through these innovations. Prototypes have been shown to support patient mobility while reducing the need for constant nursing oversight.

Who are the top competitors of Aqueduct Critical Care?

Aqueduct Critical Care's top competitors include CereVasc, Tissuemed and IRRAS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available